Urological cancers are among the most common malignancies around the world. In
particular, bladder cancer severely threatens human health due to its aggressive and …

Cancer is the main cause of morbidity and mortality worldwide, excluding infectious disease.
Because of their lack of specificity in chemotherapy agents are used for cancer treatment …

Synthetic micro/nanomotors have great potential in deep tissue imaging and in vivo drug
delivery because of their active motion ability. However, applying nanomotors with a size …

Nanotechnology-based chemotherapeutics and imaging agents represent a new era of
“cancer nanomedicine” working to deliver versatile payloads with favorable …

Platinum-based anticancer drugs occupy a crucial role in the treatment of various malignant
tumours. However, the efficacy and applicability of platinum drugs are heavily restricted by …

Chemotherapy is a primary cancer treatment strategy, the monitoring of which is critical to
enhancing the survival rate and quality of life of cancer patients. However, current …

Platinum drugs comprise of almost 50% of all currently used anticancer drugs. They are now
widely used in the clinical therapy of various solid tumors, including ovarian, head and neck …

Aggressive and recurrent gynecological cancers are associated with worse prognosis and a
lack of effective therapeutic response. Ovarian cancer (OC) patients are often diagnosed in …

Conspectus Platinum-based anticancer drugs are the mainstay of chemotherapy regimens
in clinic. Nevertheless, the efficacy of platinum drugs is badly affected by serious systemic …

Targeted delivery of therapeutics to tumor neovasculature is potentially a powerful approach
for selective cancer treatment. Integrins are heterodimeric transmembrane proteins involved …